-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Propanc Biopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from 2022 to Q3 2025.
- Propanc Biopharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 12.3M shares, a 125106% increase year-over-year.
- Propanc Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 3.97M shares.
- Propanc Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 1.42K shares.
- Propanc Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 1.74M shares, a 2449% increase from 2022.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)